<DOC>
	<DOCNO>NCT03071731</DOCNO>
	<brief_summary>This project aim assess responsiveness Glittre ADL-test acute bronchodilation patient COPD . We also aim investigate physiological perceptual response bronchodilation Glittre ADL-test . The specific objectives 1 ) To measure change time completion Glittre ADL-test induce single dose nebulized ipratropium bromide/salbutamol sulfate induce placebo patient moderate severe COPD 2 ) To compare patient moderate severe COPD CR ( minute ventilation ( VE ) , oxygen uptake ( VO2 ) , carbon dioxide production ( VCO2 ) heart rate ) symptomatic ( dyspnea leg fatigue perception ) responses Glittre ADL-test follow single dose ipratropium bromide/salbutamol sulfate placebo . We suppose among others test completion time symptom intensity lesser among patient COPD receive bronchodilator .</brief_summary>
	<brief_title>Glittre ADL-test : Responsiveness Acute Bronchodilation Chronic Obstructive Pulmonary Disease ( COPD )</brief_title>
	<detailed_description>METHODOLOGY : Study design setting : It randomize double-blind trial 34 patient moderate severe COPD complete 2 Glittre ADL-tests 15 minute follow nebulization placebo ipratropium bromide/salbutamol sulfate combination . Patients receive bronchodilator begin study ask withdraw medication 8h case short-acting bronchodilator and/or 72 h case long-acting bronchodilator visit . Those treated tiotropium 4-week washout period therapy replace ipratropium bromide . The study require 3 visit research center Institut Universitaire de Cardiologie et de Pneumologie de Québec-Université Laval ( IUCPQ ) . The 1st visit devote verify eligibility study , obtain informed consent , measure baseline characteristic include anthropometric measurement , pulmonary , low limb muscle function , well maximal exercise capacity participation activity daily life . In addition , participant familiarize Glittre test . During follow visit , subject complete two Glittre test ( 1/visit ) precede administration nebulized placebo ipratropium bromide/salbutamol sulfate ( 500 mg/2.5 mg ) administrate randomized double-blind fashion . Study visit separate &gt; 72 h &lt; 7 day . Subjects schedule attend time day throughout study . Ethics approval obtain start project subject provide write informed consent prior test . Procedure measurement : Anthropometric measurement : Weight height measure stand scale . Pulmonary function : Complete pulmonary function test include spirometry , lung volume diffuse capacity carbon monoxide obtain accord standardize technique express percent predicted9 . In addition , visit 2 3 , spirometry ( FEV1 FVC ) obtain bronchodilation determine bronchodilator-induced change FEV1 baseline respiratory condition functional test . Muscle function : Quadriceps muscle function ( force , endurance fatigue ) quantify knee extension test . The test consist one set 30 repetition angular velocity 90°/s . Amplitude angular velocity control use dynamometric isokinetic system ( Biodex , system pro 4 , Biodex Medical System , Shirley , NY , USA ) . Maximal exercise capacity : Maximal exercise capacity assess use symptom-limited incremental cycling test . Subjects seat electrically brake ergocycle ( Quinton Corival 400 ; A-H Robins , Seattle , WA ) connect portable gas analysis system ( Oxycon Mobile , Viasys Healthcare , Jaeger , Germany ) . After 5 minute rest , progressive stepwise exercise test perform individual maximal capacity . Each exercise step last 1 minute increment 10 watt apply . Minute ventilation ( VE ) , oxygen uptake ( VO2 ) , CO2 excretion ( VCO2 ) respiratory exchange ratio ( RER ) , respiratory rate ( RR ) inspiratory capacity ( IC ) heart rate ( HR ) measure rest exercise breath-by-breath basis . In addition , pulse oxygen saturation ( SpO2 ) measure rest , continuously test , end-exercise pulse oximetry ( OSM2 Hemoximeter ; Radiometer , Copenhagen , Denmark ) . Dyspnea leg fatigue perception measure modified Borg scale rest , 2 minute end exercise . Participation activity daily life : Participation activity daily life measure accelerometer-based activity monitor ( DynaPort Minimod , McRoberts BV , The Hague , The Netherlands ) . Patients instruct wear monitor waist 7 consecutive day . . They also fill diary activity week wear physical activity monitor . Functional test : The Glittre ADL test complete accord original procedure describe Skumlien5 . Briefly , patient carry weighted backpack ( 2.5 kg woman , 5.0 kg men ) instruct stand walk along flat 10-m long course . In middle course , 2-step staircase ( step 17 cm high×27 cm deep ) get across . After complete second 5 , subject face shelf contain 3 object , weigh 1 kg , position top shelf ( shoulder height ) . Participants move object , 1 1 , bottom shelf ( waist height ) floor . Once complete , participant return object , always 1 1 , bottom shelf finally top shelf . Participants walk back along circuit , climb descend stair , reach start point ( chair ) ; sit immediately begin next lap . Patients instruct complete 5 lap circuit quickly possible5 . Physiological measure well dyspnea leg fatigue perception acquire methodology use maximal exercise capacity . They also fill Multidimensional Dyspnea Profile questionnaire .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<mesh_term>Ipratropium</mesh_term>
	<mesh_term>Bronchodilator Agents</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<criteria>Diagnosis moderate severe COPD base GOLD spirometric classification able provide write informed consent able follow verbal direction test . diagnose cardiovascular , neurological , neuromuscular condition could affect ability perform test ( e.g . stroke , knee osteoarthritis ) ; currently participate structure exercise pulmonary rehabilitation program involve pulmonary rehabilitation past 6 month ; experience COPD exacerbation past 6 week receive daily dose &gt; 10mg oral Prednisone within past 3 month unable walk 4 metre without use gait aid ( e.g . walker , cane ) receive oxygen supply</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Glittre</keyword>
	<keyword>COPD</keyword>
	<keyword>functional test</keyword>
	<keyword>responsiveness</keyword>
	<keyword>bronchodilation</keyword>
</DOC>